Replies to post #73417 on CV Sciences Inc (CVSI)

[Wolf-man jack]

“ CV Sciences has a pending patent application for its product candidate CVSI-007 in the United States that will expire in 2037.

Sleuth Said;

On August 12 the patent office sent cv sciences a notice of allowance
for their second patent for cv-007.
This allows for higher doses of cbd for treatment which may be important to any potential partner.

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=165877156

“The company review its intellectual property portfolio on a periodic basis and the company will continue to broaden its portfolio in a fiscally prudent manner. The company intend to file for patent protection on its pharmaceutical products based on proprietary formulations, processes and technology.”

Wolf Said;

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=165557664